AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 117 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $257,000 | -44.6% | 4,172 | -39.3% | 0.00% | -33.3% |
| Q2 2018 | $464,000 | +24.1% | 6,870 | -0.5% | 0.00% | 0.0% |
| Q1 2018 | $374,000 | -39.4% | 6,903 | -33.2% | 0.00% | -25.0% |
| Q4 2017 | $617,000 | +963.8% | 10,334 | +213.4% | 0.00% | – |
| Q2 2016 | $58,000 | +81.2% | 3,297 | +26.3% | 0.00% | – |
| Q1 2016 | $32,000 | -30.4% | 2,610 | +36.9% | 0.00% | – |
| Q4 2015 | $46,000 | +4.5% | 1,906 | -23.6% | 0.00% | – |
| Q3 2015 | $44,000 | +340.0% | 2,494 | +345.4% | 0.00% | – |
| Q2 2015 | $10,000 | -28.6% | 560 | +28.4% | 0.00% | – |
| Q1 2015 | $14,000 | +7.7% | 436 | +0.5% | 0.00% | – |
| Q4 2014 | $13,000 | – | 434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |